GlassScriptPhysician profile
Beverly A Vavricka
NPI 1649311069
$21,525.95
in general payments reported to CMS, 2019-2025
35 companies · $530 in 2025
The $530 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,887 · 2020: $1,390 · 2021: $4,031 · 2022: $5,296 · 2023: $542 · 2024: $850 · 2025: $530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,813 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,812.99 |
| Education | $109.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $12,466.33 | 2019-2021 | |
| Organon LLC | $5,160.60 | 2021-2025 | Nexplanon, Nuvaring |
| Abbvie INC. | $831.17 | 2019-2023 | Liletta, Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $456.85 | 2021-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $320.53 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $279.06 | 2021-2025 | |
| Pfizer INC. | $273.06 | 2019-2025 | |
| Amgen INC. | $210.40 | 2019-2024 | Evenity, Prolia |
| Agile Therapeutics, INC. | $186.94 | 2021-2024 | Twirla |
| Coopersurgical, INC. | $123.45 | 2019-2025 | Endosee, Paragard T 380a |
| Hologic Sales and Service, LLC | $121.70 | 2020-2025 | Aptima, Thinprep 2000 Processor |
| Avion Pharmaceuticals | $120.61 | 2019-2021 | |
| Minerva Surgical, INC | $102.74 | 2023-2025 | |
| Therapeuticsmd, INC. | $96.55 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $92.62 | 2024-2025 | Myfembree, Gemtesa |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $83.44 | 2019 | |
| Sage Therapeutics, LLC | $74.00 | 2021-2025 | Zurzuvae |
| Exeltis, USA INC. | $69.47 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $67.09 | 2021 | |
| Allergan, INC. | $66.69 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $47.88 | 2021 | |
| Millicent US INC | $47.05 | 2020-2025 | Intrarosa, Femlyv |
| Teleflex LLC | $36.29 | 2024 | Titan Sgs |
| Vertex Pharmaceuticals Incorporated | $24.51 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $20.11 | 2020 | |
| Myovant Sciences INC. | $19.25 | 2022 | |
| Ethicon US, LLC | $18.55 | 2021 | |
| Mission Pharmacal Company | $15.72 | 2020 | |
| Covidien LP | $15.71 | 2020 | |
| Lupin INC. | $14.07 | 2019 | |
| Eisai INC. | $13.72 | 2020 | |
| Baxter Healthcare | $13.67 | 2020 | |
| Meditrina | $13.60 | 2025 | |
| Mallinckrodt Hospital Products INC. | $11.38 | 2020 | |
| Amag Pharmaceuticals, INC. | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Vavricka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.